DUAL SOURCE - true inline ESI/APCI multiplexing flexibility ✓ STAYCLEAN SOURCE and HSID INTERFACE - laminar flow for longterm reproducable results ✓ SIMPLICITY 3Q Software - intuitive data method setup and clearly arranged result reporting more
Supports rapid decisions
Support population screening to monitoring the Covid-19 spread
Flexible solution to meet different throughput requirements
Wide variety of serological assays to match different needs
PerkinElmer offer a wide range of SARS-CoV-2 antibody tests to meet the different needs. Whether you may need to quickly assess the potential infectiousness of a person or you may want to run population screening to understand and monitor the disease spread, we can help you with the right product. Our CoviScreen kit is a rapid, non-clinical test, that can be run with a drop of blood having the results in 20 minutes. It detects all the Immunoglobulins, raising the possibility to detect early stage of infection. If you need a clinical test, but still very quick to take urgent decision, you can use our SuperFlex™ Anti-SARS-CoV-2 kit.
For high-throughput processing of samples, we can offer the GSP®/DELFIA® Anti-SARS-CoV-2 IgG Kit. It is based on the robust and well-known DELFIA technology needing a drop of blood that can be absorbed on a filter paper (DBS). Such easy and cost-effective collection method allows to gather sample by remote and ship them to the clinical labs for testing, making the test extremely useful for population screening programs.
PerkinElmer SARS-COv-2 Serological Test Platforms
Superior interference removal ✓ Outstanding background equivalent concentrations and detection limits ✓ Exceptional stability more
PerkinElmer, Inc. announced that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the Company’s New Coronavirus RT-PCR test. Clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ... more
PerkinElmer, Inc. announced that after a career of more than 20 years at the Company, including the last 12 years as chief executive officer, Robert F. Friel, has decided to retire as chairman and CEO and member of the board of directors as of the end of the Company’s fiscal year on Decembe ... more
PerkinElmer announced that its board of directors has named Prahlad Singh president and chief operating officer, effective January 1, 2019. In his expanded position, Dr. Singh will have responsibility for both the Discovery and Analytical Solutions (DAS) and Diagnostics operating divisions ... more